Clinical Pharmacy Specialist Grady Health System Atlanta, Georgia
The incidence of euglycemic ketoacidosis has increased with expanded use of sodium-glucose transporter 2 (SGLT2) inhibitors as well as other therapies like dextrose-free renal replacement therapy fluids. This session will review drug and related causes of this potentially life-threatening toxicity.
